Analysen von Peter Welford
| 22.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 09.02.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.02.23 | QIAGEN Hold | Jefferies & Company Inc. | |
| 03.02.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 02.02.23 | Roche Hold | Jefferies & Company Inc. | |
| 01.02.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 01.02.23 | Novartis Buy | Jefferies & Company Inc. | |
| 01.02.23 | GSK Hold | Jefferies & Company Inc. | |
|
Werbung
|
|||
| 05.01.23 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 05.01.23 | GSK Hold | Jefferies & Company Inc. | |
| 05.01.23 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 05.01.23 | Novartis Buy | Jefferies & Company Inc. | |
| 05.01.23 | Sanofi Buy | Jefferies & Company Inc. | |
| 05.01.23 | Roche Hold | Jefferies & Company Inc. | |
| 14.12.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 12.12.22 | Novartis Buy | Jefferies & Company Inc. | |
| 07.12.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 07.12.22 | GSK Hold | Jefferies & Company Inc. | |
| 05.12.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 17.11.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 14.11.22 | Roche Buy | Jefferies & Company Inc. | |
| 10.11.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 10.11.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 09.11.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 08.11.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 28.10.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 25.10.22 | Novartis Buy | Jefferies & Company Inc. | |
| 18.10.22 | Roche Buy | Jefferies & Company Inc. | |
| 17.10.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 19.09.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 14.09.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 08.09.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 08.09.22 | GSK Hold | Jefferies & Company Inc. | |
| 08.09.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 03.08.22 | Novo Nordisk Underperform | Jefferies & Company Inc. | |
| 28.07.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 27.07.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 25.07.22 | Merck Buy | Jefferies & Company Inc. | |
| 19.07.22 | Novartis Buy | Jefferies & Company Inc. | |
| 07.07.22 | AstraZeneca Hold | Jefferies & Company Inc. | |
| 07.07.22 | Roche Hold | Jefferies & Company Inc. | |
| 23.06.22 | GSK Buy | Jefferies & Company Inc. | |
| 10.06.22 | Sanofi Buy | Jefferies & Company Inc. | |
| 08.06.22 | QIAGEN Hold | Jefferies & Company Inc. | |
| 26.05.22 | GSK Buy | Jefferies & Company Inc. | |
| 13.05.22 | Roche Hold | Jefferies & Company Inc. | |
| 11.05.22 | EVOTEC Buy | Jefferies & Company Inc. | |
| 11.05.22 | Roche Buy | Jefferies & Company Inc. | |
| 05.05.22 | Roche Buy | Jefferies & Company Inc. | |